CBN

CBN is best known for a sleep question

CBN means cannabinol, a cannabinoid distinct from THC and CBD. Sleep is the context in which it is most often discussed, but the name alone does not classify a product as sedating or show what a patient will experience.

The older evidence was thinner than the marketing language

A 2021 narrative review found that the earlier human literature lacked formal trials using validated sleep questionnaires or polysomnography. That is a description of the evidence available to the review, not a result showing that CBN improves sleep.

Two later randomised human studies give a more specific picture. In a seven-night placebo-controlled trial, adults with poor self-rated sleep received CBN alone or CBN with CBD. The CBN group reported fewer awakenings and less overall sleep disturbance, but the primary sleep-quality result was not statistically significant, and several other sleep measures did not differ. A separate trial of branded CBN formulations found no advantage over melatonin on its reported sleep measure.

CBN results depend on the preparation

Those studies used defined oral preparations and short follow-up in selected participants. They do not show that CBN in a flower, oil or multi-cannabinoid product behaves in the same way. A CBN entry on a certificate of analysis is therefore a measured constituent, not a sleep classification. For the related compound language, see the MCPH cannabinoid reference.

Related conditions

• Sleep disorders

Sources

• A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality (human randomised clinical trial, 2023).
• A Randomized, Double-Blind, Placebo-Controlled Trial of TruCBN for Improving Sleep (human randomised clinical trial, 2024).
• Cannabinol and Sleep: Separating Fact from Fiction (narrative review, 2021).